2003 Proceedings.Pdf
Total Page:16
File Type:pdf, Size:1020Kb
PROCEEDINGS of the American Academy of Forensic Sciences February 2003 Volume IX Contents Financial Disclosure Index ...........................................................1 Special Sessions ............................................................................4 Breakfast Seminars .......................................................................9 Academy-Wide Luncheons.........................................................12 Workshops & Workshorts ...........................................................13 Scientific Sessions Criminalistics.........................................................................23 Engineering Sciences.............................................................95 General.................................................................................122 Jurisprudence .......................................................................147 Odontology ..........................................................................159 Pathology/Biology ...............................................................187 Physical Anthropology ........................................................239 Psychiatry & Behavioral Science ........................................282 Questioned Documents........................................................294 Toxicology ...........................................................................300 Last Word.............................................................................324 Presenting Author Index ...........................................................327 Key Word Index ........................................................................331 Financial Disclosure It is the policy of the American Academy of Forensic Sciences to insure balance, independence, objectivity and scientific rigor in all its educational activities. All faculty participating in these programs are expected to disclose to the program audiences, prior to presenting, (1) any real or apparent conflict(s) of interest related to the content of their presentations, (2) discussion of unapproved (unlabeled) uses of pharmaceuticals/medical devices and, (3) ongoing research (preliminary) data. The intent of this disclosure is not to prevent a speaker with a significant financial or other relationship from making a presentation, but rather to provide listeners with information on which they can make their own judgments. It remains for the audience to determine whether the speaker's interest or relationships may influence the presentation with regard to the exposition or conclusion. A C Kerri A. Dugan, PhD - W2 Promega Corporation José R. Almirall, PhD - B132 Patrick S. Callery, PhD - B97 The Bode Technology Group Agilent National Institute of Justice (ChoicePoint) CETAC West Virginia University Jamie D. Dunn, BS - J6 Foster and Freeman Cassandra D. Calloway, MS - B37; B107 National Institute of Justice SYSTAT National Institute of Justice Robert O. Andres, PhD - G84 Mary E.S. Case, MD - G88 Peak Performance Technologies AAFS Pathology/Biology Section E Kenneth W. Aschheim, DDS - W24 Grant Adobe® Photoshop® Salih Cengiz, PhD - B27 John S. Edwards, PhD - B123 WinID Istanbul University Research Fund MIT, LLC, and EFT Analytical Angi M. Christensen, MA - B80 Henry Erlich, PhD - B109 U.S. Fire Administration National institute of Justice B Denise T. Chung, BS - B70 Richard J. Evans, MD - G26 Ohio University Byrne Grant Michael M. Baden, MD - W7 Robin W. Cotton, PhD - W17 National Medical Services, Inc. Orchid Cellmark F John Ballantyne, PhD - W2 Perkin-Elmer Promega Corporation Promega Corporation Scott R. Firestone, DDS - F36 The Bode Technology Group Coleen Crawford, MFA - G27 Tech-Scan Corporation (ChoicePoint) Macromedia Seth Foldy, MD - D35 Kevin D. Ballard, MD, PhD - W7 Microsoft® Milwaukee Health Department National Medical Services, Inc. Sharon R. Crowley, RN, MN - G23 EMSystem™ Lenore T. Barbian, PhD - H50 Cooper Surgical/Leisegang, Inc. Larry C. Ford, PhD - B123 Armed Forces Institute of Pathology Leisegang, Inc. MIT, LLC, and EFT Analytical National Museum of Health and Glenn S. Frysinger, PhD - D43 Medicine Leid Corporation James O. Beasley, MA - I17 National Institute of Justice Federal Bureau of Investigation Zoix Corporation David Ben-Hur, PhD - C30 Trillium D G Robert A. Bever, PhD Promega Corporation - W2 Joseph H. Davis, MD - G84 Zeno Geradts, PhD - D8 The Bode Technology Group Peak Performance Technologies Netherlands Forensic Institute (ChoicePoint) - W2 Jon Davoren, MS - B59 Joselle Germano-Presby, PhD Kristen R. Beyer, PhD - I17 Promega Corporation ABI AFLP Plant Mapping Kit - B19 Federal Bureau of Investigation Qiagen National Institute of Justice - B19 Joan M. Bienvenue, MS - B39 Irena Dawidson, DDS, PhD - F29 QIAGEN Plant DNeasy Mini-Kit -B19 Amersham Pharmacia National Board of Forensic Medicine Robert C. Giles, PhD - W17 Federal Bureau of Investigation Lydia M. de Castro, BS - B71 Orchid Cellmark ReproGel New York City OCME Perkin-Elmer Robert D. Blackledge, MS - B134 James V. DeFrancesco, PhD - B18 Promega Corporation Foster & Freeman U.S. Department of Justice Kelly E. Gillis, MA - D4 Pilkington Glass James M. DiFrancesco, MFS - B69 Superglue® Pittsburgh Plate Glass Qiagen Edward M. Golenberg, PhD - W2 Renishaw, Inc. John A. DiMaggio, RPh, DPM - H7 Promega Corporation Cherisse E. Boland, BS - B4 Biofoam Casting Foam The Bode Technology Group Applied Biosystems Smithers Identicator Shoeprint (ChoicePoint) Richard S. Brown, MS - C2 System William E. Grant, MA - H11 Mau, Inc. Paula M. Do - G33 U.S. Army Central Identification Jeffrey R. Burkes, DDS - W24 California State University at Laboratory - Hawaii Adobe® Photoshop® Bakersfield Matthew Greenhalgh, BSc - W17 WinID© Student Research Scholars Orchid Cellmark JoAnn Buscaglia, PhD - B135 Kerri Dugan, PhD - B111 Perkin-Elmer Federal Bureau of Investigation Applied Biosystems Promega Corporation 1 Financial Disclosure Catherine Grgicak, BSc, BEd - B8 L Michelle L. Miller, BS, MA - H66 Chelex Department of Energy Grant Promega DNA 10th System Carll Ladd, PhD - B87 University of Tennessee Qiagen QIAamp DNA Mini Kit ReliaGene Technologies, Inc. Heather Miller Coyle, PhD Nicole A. Gross, BA - B67 Krista E. Latham, BS - H46 Promega Corporation - W2 ABI 3100 Connective Tissue Research Award The Bode Technology Group Promega PowerPlex® 16 Jumi Lee, PhD - B139 (ChoicePoint) - W2 Qiagen QIAamp DNA Blood Mini Kit CRAIC Technologies Ann Marie W. Mires, PhD - H63 Lisa L. Grossweiler, MS - B56 Craig S. Leibelt, MS - B58 Sensable Technologies, Inc. CODISmt Applied Biosystems Christine M. Moore, PhD - K33 Orchid Cellmark James M. Lewis, DMD - F48 U.S. Drug Testing Laboratories Amy C. Gruszecki, DO - K2 Nikon Richard A. Morehead, BS - K7 Metaxalone Brian S. Lindblom, BA - J13 Restek Corporation Pikaso Software, Inc. Write-On James Mueller - C31 Handwriting Comparison Software Malcolm Pirnie, Inc. H Barbara E. Llewellyn, MS - B55 Waterloo Profiler Applied Biosystems Thomas P. Muller, PhD - W19 Erin K. Hanson, BS - B64 Illinois Criminal Justice Information Simon & Schuster Publisher National Institute of Justice Authority St. Martin's Press Ross J. Harper, MSci - B40 Orchid Cellmark Rebecca A. Murray, BS - K12 Florida International University Katherine Long, BS - W17 DanceSafe Test Kit™ Deborah L. Hobson, BS, MPH - W17 Orchid Cellmark Alan L. Myers, PharmD - B41 Orchid Cellmark Perkin-Elmer National Institute of Justice Perkin-Elmer Promega Corporation West Virginia University Promega Corporation Patricia Loudon, PhD - W2 Mitchell M. Holland, PhD - W2 Promega Corporation Promega Corporation The Bode Technology Group O TheBode Technology Group (ChoicePoint) (ChoicePoint) Alex Lowe - W17 William R. Oliver, MD - G80 Katie M. Horsman, BS, MS - B2 Orchid Cellmark U.S. Government Violent Web Sites University of Virginia Perkin-Elmer Kerry L. Opel, MA - B70 Jonathan Hoyle, BS - W2 Promega Corporation Ohio University Promega Corporation Alexandra L. Lowe, MSc - W2 Michael Osterheider, MD - W19 The Bode Technology Group Promega Corporation Simon & Schuster Publisher (ChoicePoint) The Bode Technology Group St. Martin's Press Min Huang, PhD - B140 (ChoicePoint) Stephen D. Ousley, PhD - H13 National Institute of Justice Smithsonian Institute Karl H.J. Hummel, BSc - W17 Orchid Cellmark M Perkin-Elmer Promega Corporation Scott MacFabe, HBSc - C31 P Malcolm Pirnie, Inc. Waterloo Profiler Walther Parson, PhD - W2 J Paul C. Martin, PhD - B138 Promega Corporation CRAIC Technologies TheBode Technology Group John P. Jasper, PhD - B123 Julie L. Maybruck, BS - B62 (ChoicePoint) MIT, LLC, and EFT Analytical Graduate Student Alumni Joseph L. Peterson, DCrim, AB - B127 Kimberley Johnston, MSc, BA - B128 Research Award Bureau of Justice Statistics Centre of Forensic Sciences Ohio State University Eric W. Phillips, BS - K9 John F. McClelland, PhD - J7 ThermoFinnigan Harrick Scientific SplitPea ATR Gina M. Pineda, MS - W17 K Accessory Orchid Cellmark National Institute of Justice Perkin-Elmer Kristy Kadash, PhD - B108 Thermo Nicolet Avatar FT-IR Promega Corporation Cybergenetics, Inc. TrueAllele™ Spectrometer Seth Pitkin - C31 Masaaki Kasamatsu, MS - B131 D. Ryan McGlothlin, BS - C7 Malcolm Pirnie, Inc. National Police Agency - Japan Department of Defense Waterloo Profiler Margaret C. Kline, MS - B60 James J. McKenna, PhD - G93 Gerry A. Polverento, BA - D32 National Institute of Justice University of Notre Dame Michigan Department of Community Robert D. Koons, PhD - B120 Susan D. McMillen, DDS, MS - F18 Health Federal Bureau of